CAMP4 Therapeutics Corporation
USD3.19
-0.13 (-3.92%)
CEO
Joshua Mandel-Brehm
IPO Date
2024-10-11
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$3.35
Prev. Close
$3.32
Day Low
$3.16
Day High
$3.45
52W Low
$1.32
52W High
$7.75
Market Cap
$0.07B
Volume
0.14M
| 28,000 |
| $4.34 |
| 12 Jun 2026 | Schwab Andrew J. | director, 10 percent owner: | A-Award | Acquired | 28,000 | $4.34 |
| 12 Jun 2026 | Holtzman Steven H | director | A-Award | Acquired | 28,000 | $4.34 |
| 12 Jun 2026 | Stewart Murray | director | A-Award | Acquired | 28,000 | $4.34 |
| 12 Jun 2026 | Nashat Amir | director, 10 percent owner: | A-Award | Acquired | 28,000 | $4.34 |
| 3 Apr 2026 | Tardiff Daniel | Chief Scientific Officer | A-Award | Acquired | 170,000 | $4.46 |
| 3 Apr 2026 | Maricich Yuri | Chief Medical Officer | A-Award | Acquired | 215,000 | $4.46 |
| 3 Apr 2026 | Gold Kelly | Chief Financial Officer | A-Award | Acquired | 215,000 | $4.46 |
| 3 Apr 2026 | Mandel-Brehm Josh | director, officer: Chief Executive Officer | A-Award | Acquired | 580,000 | $4.46 |